Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Exp Neurol. 2020 Mar 3;328:113272. doi: 10.1016/j.expneurol.2020.113272

Figure 14. PBML CCR5 expression in untreated HIV+ patient vs. HIV− controls.

Figure 14.

Comparative histograms of HIV+ cART-naïve patients and age- and sex-matched controls show increased mean % of CD14+ CD16+ (A) and CD14+ CD16+ CCR5+ (B) monocytes in HIV+ patients, as well as increased CCR5 mean fluorescent intensity (marker of receptor density per cell) in CD3+ CD4+ (C) and CD3+ CD8+ (D) T-lymphocytes, suggesting a potential role in pathogenic leukocyte trafficking in HIV−DSN.